Skip to content

Comparison of Two Marketed Silicone Hydrogel Lenses

One Month Clinical Comparison of Lotrafilcon B and Samfilcon A

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02495948
Enrollment
168
Registered
2015-07-13
Start date
2015-07-31
Completion date
2015-10-31
Last updated
2016-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Brief summary

The purpose of this study is to evaluate cholesterol sorption by AIR OPTIX® AQUA lenses compared to ULTRA lenses after 30 days of wear.

Interventions

DEVICEHydrogen peroxide solution

Used as a cleaning, disinfection, and storage solution for silicone hydrogel and soft contact lenses

DEVICESaline solution

Used for rinsing contact lenses, as needed

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sign informed consent document; * Vision correctable to 20/40 Snellen (feet) or better in each eye at distance with both study contact lenses; * Willing to wear study lenses on a daily basis (minimum 5 days/week, 8 hours/day) and attend all study visits; * Successful wear of single-vision spherical, 2-week/ monthly replacement silicone hydrogel contact lenses in both eyes daily wear during the past 2 months for a minimum of 5 days/week, 8 hours/day. (Note: Monovision is included); * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear (within 7 days of enrollment, or current); * History of herpetic keratitis, corneal surgery or irregular cornea; * Any use of systemic or ocular medications within the past 30 days for which contact lens wear could be contraindicated as determined by the investigator; * Monocular (only 1 eye with functional vision) or fit with only one lens; * Current or past AIR OPTIX® AQUA or ULTRA lens wearers; * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Mean Ex-vivo Cholesterol Deposits After 30 Days of WearDay 30, each productThe contact lens (right eye) was removed and stored dry and frozen until analysis. Total cholesterol deposits (cholesterol and cholesterol esters) were extracted from the lens and measured in micrograms. Lower deposits indicate increased lens performance. Study originally intended to analyze 36 lenses per arm, but actual number of lenses analyzed was less due to measurement error.

Participant flow

Recruitment details

Participants were recruited from 10 investigational sites located in the US.

Pre-assignment details

Of the 168 enrolled, 1 participant was exited as a screen failure prior to randomization. This reporting group includes all randomized participants (167).

Participants by arm

ArmCount
Overall
Lotrafilcon B and samfilcon A contact lenses worn during Period 1 and Period 2 in a crossover assignment, as randomized.
167
Total167

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1, First 30 Days of WearAdverse Event01
Period 2, Second 30 Days of WearWithdrawal by Subject11

Baseline characteristics

CharacteristicOverall
Age, Continuous31.9 years
STANDARD_DEVIATION 9.01
Gender
Female
130 Participants
Gender
Male
37 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1680 / 1660 / 167
serious
Total, serious adverse events
0 / 1680 / 1660 / 167

Outcome results

Primary

Mean Ex-vivo Cholesterol Deposits After 30 Days of Wear

The contact lens (right eye) was removed and stored dry and frozen until analysis. Total cholesterol deposits (cholesterol and cholesterol esters) were extracted from the lens and measured in micrograms. Lower deposits indicate increased lens performance. Study originally intended to analyze 36 lenses per arm, but actual number of lenses analyzed was less due to measurement error.

Time frame: Day 30, each product

Population: Intent-to-Treat analysis set

ArmMeasureValue (MEAN)Dispersion
AIR OPTIX AQUA (AOA)Mean Ex-vivo Cholesterol Deposits After 30 Days of Wear1.63 microgramsStandard Deviation 2.21
ULTRAMean Ex-vivo Cholesterol Deposits After 30 Days of Wear4.89 microgramsStandard Deviation 3.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026